◆ 会议时间：2021年6月4日至8日
◆ 会议地点：虚拟会议-VIRTUAL

◆ 会议简介：

2021年美国临床肿瘤学会(ASCO)年会-虚拟会议将于2021年6月4日至8日举行。

美国临床肿瘤学会年会(ASCO年会)是世界上规模最大、学术水平最高、最具权威的临床肿瘤学会议，汇集了众多世界一流的肿瘤学专家，和与会者们一起分享探讨当前国际最前沿的临床肿瘤学科研成果和肿瘤治疗技术，很多重要的研究发现和临床试验成果也会选择在ASCO年会上进行首次发布。2020年ASCO年会(虚拟会议)数据：总注册人数44,750人，其中专业人士42,000人；国际与会者21,800人（中国有1,842人注册参会）。

美国临床肿瘤学会(ASCO)成立于1964年，是世界上最大、最具影响力的肿瘤专业学术组织，致力于癌症的预防、治疗及改善对患者的护理，ASCO是唯一涵盖所有肿瘤亚专科的组织。ASCO在全球150多个国家和地区拥有超过45000名成员，其中国际会员约占协会会员总数的三分之一，会员包括肿瘤学领域宣及其亚专科的临床肿瘤科医师、参与认可的肿瘤学训练计划的医师和医疗专家、肿瘤科护士以及肿瘤科执业医师等等。——未经本站许可，禁止复制摘录转载本站任何内容-领域国际医学会议网。

重要日期：

2021 ASCO Annual Meeting

OCTOBER 1, 2020
ASCO Voices Auditions Open

NOVEMBER 12, 2020
Abstract Submission Opens/摘要提交开始

点此提交摘要>>>Submit Abstract>>>

NOVEMBER 15, 2020
ASCO Voices Audition Deadline

LATE JANUARY 2021
Member Registration and Hotel Reservations Opens

EARLY FEBRUARY 2021
Registration and Hotel Reservations Opens to All

FEBRUARY 17, 2021 at 11:59 PM ET
Abstract Submission Deadline/摘要提交结束

MARCH 18, 2021
Late-breaking Submission Deadline (Abstract placeholder is required by February 17 deadline)/LBA摘要提交结束

APRIL 2, 2021
Abstract Notifications sent to First Author/摘要是否被接收通知

APRIL 11, 2021
Abstract Withdrawal Deadline

APRIL 28, 2021
Abstract Titles Released

APRIL 28, 2021
Early Registration Deadline

MAY 19, 2021 at 5:00 PM ET
Abstracts released on ASCO. org

JUNE 4-8, 2021
ASCO Annual Meeting

Abstract Submission

点此查看更多摘要提交政策及相关信息>>>

摘要提交费/Submission Fee: A $60 (USD) nonrefundable submission fee will be charged per abstract submitted. Payment is due at the time of submission. Credit cards are the only accepted form of payment. Checks, wire transfers, and purchase orders will not be accepted.

• Payment waivers: First authors from low-income countries, as defined by the World Bank, may apply for a payment waiver. These countries include: Afghanistan, Benin, Burkina Faso, Burundi, Central African Republic, Chad, Democratic Republic of Congo, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Democratic People's Republic of Korea, Liberia, Madagascar, Malawi, Mali, Mozambique, Nepal, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Syrian Arab Republic, Tajikistan, Tanzania, Togo, Uganda, and the Republic of Yemen. At this time, Lower-Middle Income Countries are not eligible for this waiver. 

Abstract Eligibility

As your prepare your submission to the Meeting, please make note of the following details:

• All types of oncology-related research are eligible for submission. Please note: case reports are not accepted.
• Abstract should address scientific questions, detail clinical observations, or contain primary scientific data.
• Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown. 
• Interim analysis of a prospective randomized clinical trial will be considered if it is performed as planned in the original protocol and is statistically valid.
• Abstracts of clinically-related subjects should be combined into a single abstract. Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.

Author & Sponsor Eligibility

As you prepare your submission to the Meeting, please make note of the following author and sponsorship eligibility criteria:

• Individuals may submit up to 2 regular abstracts as the first author.
• Individuals may submit an unlimited number of Trials in Progress abstracts.
• ASCO membership is not required to submit an abstract, however each abstract must be sponsored by an ASCO member.
  • Full Members (including Early Career and International in Developing Countries) may submit and sponsor their own abstract and may sponsor other abstracts
  • Allied Physician/Doctoral Scientist members may only submit and sponsor their own abstract as first author
  • Members in Training may submit and sponsor their own abstract as first author with approval from their training program director
  • Advanced Practice Providers, Affiliated Health Professionals, Patient Advocates, Practice Administrators, and Student/Non-Oncology Residents may submit an abstract with a sponsor signature from a Full Member
  • Emeritus members retain the abstract sponsorship rights of their previous membership category
• The sponsor must:
  • Be an ASCO Full Member, Allied Physician/Doctoral Scientist1 or a Member in Training2 in good standing3 
  • Verify the contents of the abstract and support its data
  • Comply with the Confidentiality Policy
• The sponsor does not need to be an author of the abstract.
• An ASCO Full Member may sponsor multiple abstracts including his or her own abstract. Affiliated Health Professionals and Allied Physicians/Doctoral Scientists can sponsor their own abstracts and Full Members can sponsor their own abstracts and the abstracts of others.